The current study found that XAGE1-positive ovarian cancer patients had considerably greater levels of XAGE1 gene expression than benign tumor patients, indicating that the XAGE1 gene has a high specificity as a diagnostic marker for distinguishing malignant from benign ovarian cancer. This evidence concerns the gene XAGE1A and ovarian carcinoma.